Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempus AI

68.34
+2.874.38%
Post-market: 68.470.1300+0.19%19:16 EDT
Volume:8.24M
Turnover:557.76M
Market Cap:11.83B
PE:-13.89
High:69.25
Open:66.06
Low:65.41
Close:65.47
Loading ...

Tempus AI Jumped 4% On ARK Buying After Tumbling 19% On Wednesday On Short Selling

Tiger Newspress
·
29 May

Tempus AI Stock (TEM) Could See ‘Tesla or Nvidia-Type Inflection,’ Claims Short Seller

TIPRANKS
·
29 May

Cathie Wood Ditches $5.6M More Tesla While Elon Musk Quits Government Role — Doubles Down On AI Stock Under Attack By Short Sellers

Benzinga
·
29 May

Stock Track | Tempus AI Stock Soars 5% Despite Short-Seller Attack as ARK Invests

Stock Track
·
29 May

Post-Bell|US Shares Finish Down; Nvidia Shares Rise 5% After Earnings; Unity Soars 13%; Tempus AI Drops 19%; GameStop Falls 11%

Tiger Newspress
·
29 May

A Cathie Wood Favorite Is Falling: Why Tempus AI Stock Is Imploding Today

Motley Fool
·
29 May

Tempus AI Shares Extend Losses, Last Down 14.8%

THOMSON REUTERS
·
28 May

BRIEF-Spruce Point Capital Management Announces Investment Opinion

Reuters
·
28 May

Stock Track | Tempus AI Plummets 5.36% as Spruce Point Issues Strong Sell Report and Announces Short Position

Stock Track
·
28 May

Tempus AI Stock Sinks 10% Following Spruce Point Short Report

THOMSON REUTERS
·
28 May

Spruce Point short Tempus AI, sees 50%-60% potential downside risk

TIPRANKS
·
28 May

Spruce Point Capital Issues Strong Sell Opinion on Tempus AI, Citing Concerns Over AI Capabilities and Financial Practices

Reuters
·
28 May

Spruce Point: Short Position in Tempus AI

THOMSON REUTERS
·
28 May

Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Tempus AI, Inc. (Nasdaq: Tem)

THOMSON REUTERS
·
28 May

Tempus AI Inc. Celebrates a Decade of Discovery with 1,500 Research Projects Advancing Precision Medicine

Reuters
·
28 May

Stock Track | Tempus AI Soars 5.31% as Subsidiary Ambry Genetics Reports Breakthrough in Rare Disease Diagnosis

Stock Track
·
27 May

Ambry Genetics, a Tempus AI Subsidiary, Enhances Rare Disease Diagnosis with Proactive Exome Reanalysis

Reuters
·
27 May

Tempus AI Inc. Concluded Annual Stockholders Meeting

Reuters
·
23 May

James William Rogers, CFO of Tempus AI Inc., Reports Disposal of Common Shares

Reuters
·
23 May

Andrew Polovin, EVP and General Counsel, Reports Disposal of Common Shares of Tempus AI Inc

Reuters
·
23 May